Analyzing QT Imaging (NASDAQ:QTI) & Hyperfine (NASDAQ:HYPR)

QT Imaging (NASDAQ:QTI) and Hyperfine (NASDAQ:HYPR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation.

Earnings & Valuation

This table compares QT Imaging and Hyperfine”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QT Imaging	$4.00 million	2.72	-$4.03 million	N/A	N/A
Hyperfine	$11.03 million	6.42	-$44.24 million	($0.57)	-1.70

QT Imaging has higher earnings, but lower revenue than Hyperfine.

Volatility and Risk

QT Imaging has a beta of -0.23, indicating that its stock price is 123% less volatile than the S&P 500. Comparatively, Hyperfine has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Insider and Institutional Ownership

24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 75.4% of QT Imaging shares are owned by company insiders. Comparatively, 29.4% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares QT Imaging and Hyperfine’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
QT Imaging	N/A	N/A	-65.94%
Hyperfine	-309.42%	-57.54%	-50.38%

Analyst Recommendations

This is a summary of current ratings and recommmendations for QT Imaging and Hyperfine, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QT Imaging	0	0	0	0	0.00
Hyperfine	0	1	1	0	2.50

Hyperfine has a consensus target price of $1.60, suggesting a potential upside of 64.93%. Given Hyperfine’s stronger consensus rating and higher possible upside, analysts clearly believe Hyperfine is more favorable than QT Imaging.

Summary

Hyperfine beats QT Imaging on 7 of the 12 factors compared between the two stocks.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

About Hyperfine

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.